Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Quintiles | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Quintiles

Product Development revenues up 9% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles

4Q Revenues: $1.5 billion (+8%)

4Q Earnings: $108.1 million (earnings were $88,444 4Q14)

FY Revenues: $5.7 billion (+5%)

FY Earnings: $388.3 million (+9%)

Comments: Product Development revenues were $845.7 million in the quarter, up 9% but negatively impacted by $22.4 million from unfavorable foreign exchange. The Integrated Healthcare Services revenues were $282.9 million, down 2%, negatively impacted by $13.1 million from unfavorable foreign exchange. New business of $1.49 billion was recorded in the quarter, representing a book-to-bill ratio of 1.32.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics